FGF2 and colon carcinoma: In patients with colon carcinoma (n = 262), high ANGP2 and VEGF‐A expression, individually, predicts a somewhat worse probability of survival compared to low ANGPT2 or VEGF‐A expression, whereas high or low ANGPT1, PDGFA, and FGF2 expression has no impact (Fig 2D).